{"id":"mesa","rwe":[{"pmid":"41902502","year":"2026","title":"Estimating population structure using epigenome-wide methylation data.","finding":"","journal":"Briefings in bioinformatics","studyType":"Clinical Study"},{"pmid":"41891521","year":"2026","title":"Urethral injury during vaginal delivery: Incidence, management and long-term outcomes.","finding":"","journal":"International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics","studyType":"Clinical Study"},{"pmid":"41891027","year":"2026","title":"CARDIAC-FM: A Multimodal Foundation Model for Cardiovascular Risk Prediction Using ECG and Cardiac MRI.","finding":"","journal":"medRxiv : the preprint server for health sciences","studyType":"Clinical Study"},{"pmid":"41884897","year":"2026","title":"Plasma Proteins Associated With Psychosocial Factors and Heart Disease: The Jackson Heart Study.","finding":"","journal":"Arteriosclerosis, thrombosis, and vascular biology","studyType":"Clinical Study"},{"pmid":"41867182","year":"2026","title":"A Common Missense Variant, W335S, in β2-Glycoprotein I (APOH) is Associated with Increased Autoantibody Levels but Reduced Venous Thromboembolism Risk.","finding":"","journal":"medRxiv : the preprint server for health sciences","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Off-Patent","category":"patent"},{"label":"Generic Available","category":"availability"},{"label":"Active","category":"status"},{"label":"Meda Pharms","category":"company"}],"phase":"marketed","safety":{"commonSideEffects":[{"effect":"Gas/Flatulence","drugRate":"6%","severity":"common","organSystem":""},{"effect":"Flu","drugRate":"5%","severity":"common","organSystem":""},{"effect":"Fever","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Leg/Joint pain","drugRate":"2%","severity":"common","organSystem":""},{"effect":"Hemorrhoids","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Rectal pain","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Hair loss","drugRate":"1%","severity":"common","organSystem":""}],"contraindications":["Anemia","Disease of liver","Interstitial nephritis","Kidney disease","Minimal change disease","Neutropenic disorder","Pyloric obstruction"],"seriousAdverseEvents":[{"effect":"Hepatic failure","drugRate":"","severity":"serious"},{"effect":"Severe cutaneous adverse reactions","drugRate":"","severity":"serious"},{"effect":"Hypersensitivity reactions","drugRate":"","severity":"serious"},{"effect":"Renal impairment","drugRate":"","severity":"serious"},{"effect":"Mesalamine-induced acute intolerance syndrome","drugRate":"","severity":"serious"},{"effect":"Photosensitivity","drugRate":"","severity":"serious"},{"effect":"Nephrolithiasis","drugRate":"","severity":"serious"},{"effect":"Myocarditis","drugRate":"","severity":"serious"},{"effect":"Pericarditis","drugRate":"","severity":"serious"},{"effect":"Pancreatitis","drugRate":"","severity":"serious"}]},"trials":[],"aliases":[],"company":"Meda Pharms","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=MESA","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:52:57.817388+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:53:04.003984+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MESA","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:53:04.778910+00:00"}},"allNames":["mesa"],"offLabel":[],"synonyms":[],"timeline":[{"date":"1987-12-24","type":"positive","source":"FDA Orange Book","milestone":"Rowasa approved — 4GM/60ML"},{"date":"1992-01-31","type":"positive","source":"FDA Orange Book","milestone":"Asacol approved — 400MG"},{"date":"2000-01-01","type":"neutral","source":"FDA Orange Book","milestone":"Rights transferred from Air Force Military Medical University, China to Meda Pharms"},{"date":"2001-01-05","type":"positive","source":"FDA Orange Book","milestone":"Canasa approved — 500MG"},{"date":"2004-07-08","type":"positive","source":"FDA Orange Book","milestone":"Pentasa approved — 500MG"},{"date":"2007-01-16","type":"positive","source":"FDA Orange Book","milestone":"Lialda approved — 1.2GM"},{"date":"2008-05-29","type":"positive","source":"FDA Orange Book","milestone":"Asacol Hd approved — 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"},{"date":"2008-10-31","type":"positive","source":"FDA Orange Book","milestone":"Apriso approved — 375MG"},{"date":"2013-02-01","type":"positive","source":"FDA Orange Book","milestone":"Delzicol approved — 400MG"},{"date":"2025-04-14","type":"neutral","source":"FDA Orange Book","milestone":"Generic entry — 23 manufacturers approved"}],"approvals":[],"ecosystem":[],"mechanism":{"target":"Arachidonate 5-lipoxygenase, Peroxisome proliferator-activated receptor gamma, Prostaglandin G/H synthase 1","modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Mesa's mechanism of action involves binding to a specific receptor or enzyme, which triggers a cascade of downstream effects that ultimately lead to its therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=mesa","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=mesa","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-31T10:42:13.770460","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:53:07.047005+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"mesa","indications":{"approved":[{"name":"Chronic ulcerative proctitis","diseaseId":"chronic-ulcerative-proctitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chronic ulcerative rectosigmoiditis","diseaseId":"chronic-ulcerative-rectosigmoiditis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Ulcerative colitis","diseaseId":"ulcerative-colitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Ulcerative colitis in remission","diseaseId":"ulcerative-colitis-in-remission","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"currentOwner":"Meda Pharms","drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[],"trialDetails":[{"nctId":"NCT06467604","phase":"","title":"CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Davis","startDate":"2024-11-01","conditions":["Obesity"],"enrollment":7,"completionDate":"2026-04-01"},{"nctId":"NCT00005487","phase":"","title":"Multi-Ethnic Study of Atherosclerosis (MESA)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1999-01","conditions":["Atherosclerosis","Cardiovascular Diseases","Heart Diseases","Coronary Artery Disease","Coronary Disease","Stroke","Myocardial Infarction","Heart Failure","Diabetes Mellitus, Type 2","Hypertension","Diabetes Mellitus"],"enrollment":6418,"completionDate":"2030-12"},{"nctId":"NCT07238088","phase":"NA","title":"Active Mammography and Counseling","status":"NOT_YET_RECRUITING","sponsor":"University of Puerto Rico Comprehensive Cancer Center","startDate":"2026-01-26","conditions":["Breast Cancer Prevention"],"enrollment":1020,"completionDate":"2028-02-28"},{"nctId":"NCT03981380","phase":"","title":"11C-PIB PET Study in MESA at Columbia University","status":"COMPLETED","sponsor":"José A. Luchsinger","startDate":"2020-08-01","conditions":["Cognitive Impairment","Vascular Diseases","Alzheimer Disease","Atherosclerosis"],"enrollment":59,"completionDate":"2024-02-05"},{"nctId":"NCT03901534","phase":"NA","title":"Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD","status":"TERMINATED","sponsor":"Columbia University","startDate":"2023-01-01","conditions":["Interstitial Lung Disease","Obstructive Sleep Apnea"],"enrollment":2021,"completionDate":"2023-10-16"},{"nctId":"NCT01397721","phase":"","title":"Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary","status":"COMPLETED","sponsor":"Columbia University","startDate":"2009-05","conditions":["Chronic Obstructive Pulmonary Disease"],"enrollment":359,"completionDate":"2018-04-30"},{"nctId":"NCT02925195","phase":"NA","title":"Individualized Response to Vitamin D Treatment Study","status":"COMPLETED","sponsor":"University of Washington","startDate":"2017-01-11","conditions":["Characteristics That Modify the Response to Cholecalciferol Treatment"],"enrollment":666,"completionDate":"2022-03-04"},{"nctId":"NCT05631821","phase":"NA","title":"3-D Correction of Adolescent Idiopathic Scoliosis (AIS) With Differential Metals","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2014-10","conditions":["Juvenile and Adolescent Idiopathic Scoliosis"],"enrollment":20,"completionDate":"2022-11"},{"nctId":"NCT02761746","phase":"NA","title":"Motivational Enhancement System for Adherence (MESA) for Youth Starting ART","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2016-02-22","conditions":["Medication Adherence"],"enrollment":155,"completionDate":"2021-04-30"},{"nctId":"NCT01551550","phase":"NA","title":"Shunt Tube Exposure Prevention Study","status":"COMPLETED","sponsor":"BioTissue Holdings, Inc","startDate":"2013-06","conditions":["Glaucoma"],"enrollment":82,"completionDate":"2019-08-03"},{"nctId":"NCT02590380","phase":"NA","title":"Comparing Pedicle Screw Systems for the Treatment of Adolescent Paediatric Spine Deformity","status":"WITHDRAWN","sponsor":"K2M, Inc.","startDate":"2022-09","conditions":["Adolescent Idiopathic Scoliosis"],"enrollment":0,"completionDate":"2030-09"},{"nctId":"NCT04183907","phase":"NA","title":"Preventing Risk for Metabolic Syndrome in Workaholics: An Intervention","status":"COMPLETED","sponsor":"Simon Fraser University","startDate":"2021-02-01","conditions":["PreDiabetes"],"enrollment":210,"completionDate":"2021-09-14"},{"nctId":"NCT02631239","phase":"PHASE3","title":"MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2016-03-16","conditions":["Extranodal NK/T-cell Lymphoma, Nasal Type"],"enrollment":256,"completionDate":"2022-07-17"},{"nctId":"NCT02062606","phase":"","title":"MESA Rail™ AIS Study - Preservation of Curve Correction","status":"TERMINATED","sponsor":"K2M, Inc.","startDate":"2014-05","conditions":["Adolescent Idiopathic Scoliosis"],"enrollment":188,"completionDate":"2020-02-23"},{"nctId":"NCT03803878","phase":"","title":"Translation and Validation of MESA Questionnaire of Chinese Language Version","status":"UNKNOWN","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-03-01","conditions":["Questionnaire","Mixed Urinary Incontinence","Urgency-predominant Mixed Urinary Incontinence"],"enrollment":300,"completionDate":"2022-12-30"},{"nctId":"NCT02825147","phase":"PHASE2","title":"Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma","status":"COMPLETED","sponsor":"Ruijin Hospital","startDate":"2013-09","conditions":["Nasal Type Extranodal NK/T-Cell Lymphoma"],"enrollment":40,"completionDate":"2017-07"},{"nctId":"NCT01009749","phase":"NA","title":"Motivational Enhancement System for Adherence","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2009-08","conditions":["HIV"],"enrollment":76,"completionDate":"2011-05"},{"nctId":"NCT03035526","phase":"","title":"Sex Hormones and Pericardial Adipose Tissue","status":"COMPLETED","sponsor":"Gulhane School of Medicine","startDate":"2000-01","conditions":["Pericardial Adipose Tissue and Sex Hormones"],"enrollment":3213,"completionDate":"2002-01"},{"nctId":"NCT00402922","phase":"","title":"Evaluating the Association Between Pericardial Fat and Coronary Heart Disease - Ancillary to MESA","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2006-08","conditions":["Coronary Disease"],"enrollment":6814,"completionDate":"2012-05"},{"nctId":"NCT01714141","phase":"NA","title":"Multi-Component Technology Intervention for Minority Emerging Adults With Asthma","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2011-12","conditions":["Asthma","Poor Medication Adherence"],"enrollment":48,"completionDate":"2015-09"},{"nctId":"NCT00612365","phase":"","title":"Association Between Abdominal Body Composition, Inflammation, and Risk for Cardiovascular Disease (The MESA ABD Study)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2007-09","conditions":["Cardiovascular Diseases","Obesity"],"enrollment":1975,"completionDate":"2013-06"},{"nctId":"NCT00613158","phase":"","title":"Using Differences in Peripheral Blood Leukocyte Gene Expression to Determine Cardiovascular Disease Risk","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2007-03","conditions":["Atherosclerosis","Cardiovascular Diseases"],"enrollment":120,"completionDate":"2010-02"},{"nctId":"NCT00091494","phase":"","title":"Socioeconomic Patterning of Inflammation and Hemostasis - Ancillary to MESA","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2004-09","conditions":["Atherosclerosis","Cardiovascular Diseases","Heart Diseases","Inflammation","Blood Coagulation Disorders"],"enrollment":1000,"completionDate":"2008-06"},{"nctId":"NCT00063557","phase":"","title":"Neighborhoods and CVD Risk in a Multiethnic Cohort - Ancillary to MESA","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2003-06","conditions":["Cardiovascular Diseases","Coronary Disease","Heart Diseases","Atherosclerosis"],"enrollment":0,"completionDate":"2007-04"},{"nctId":"NCT00041444","phase":"","title":"Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2002-06","conditions":["Atherosclerosis","Cardiovascular Diseases","Coronary Arteriosclerosis","Coronary Disease","Cerebrovascular Disorders","Heart Failure, Congestive","Myocardial Infarction","Heart Diseases","Diabetes Mellitus, Non-insulin Dependent","Hypertension","Diabetic Retinopathy","Macular Degeneration","Diabetes Mellitus"],"enrollment":6176,"completionDate":"2006-11"},{"nctId":"NCT00064532","phase":"","title":"Serum Sex Hormone Levels and Subclinical Atherosclerosis - Ancillary to MESA","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2003-07","conditions":["Cardiovascular Diseases","Atherosclerosis","Coronary Arteriosclerosis","Coronary Disease","Heart Diseases"],"enrollment":6173,"completionDate":"2008-06"},{"nctId":"NCT01933282","phase":"PHASE2","title":"MESA Treatment for NK/T Cell Lymphoma","status":"UNKNOWN","sponsor":"Air Force Military Medical University, China","startDate":"2013-01","conditions":["Lymphoma, Extranodal NK-T-Cell"],"enrollment":100,"completionDate":"2015-01"},{"nctId":"NCT00065780","phase":"","title":"Ventricular Size and Value Calcification Measures by Computed Tomography - Ancillary to MESA","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2003-08","conditions":["Cardiovascular Diseases","Heart Diseases","Atherosclerosis","Coronary Arteriosclerosis"],"enrollment":6814,"completionDate":"2008-07"},{"nctId":"NCT00059124","phase":"","title":"Aortic Calcium: Epidemiology and Progression -- Ancillary to MESA","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2003-03","conditions":["Cardiovascular Diseases","Heart Diseases","Atherosclerosis","Coronary Arteriosclerosis"],"enrollment":1980,"completionDate":"2008-02"},{"nctId":"NCT00063440","phase":"","title":"Epidemiology of Carotid IMT Progression in MESA - Ancillary Study","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2003-06","conditions":["Atherosclerosis","Cardiovascular Diseases","Heart Diseases","Carotid Artery Diseases","Coronary Arteriosclerosis"],"enrollment":5610,"completionDate":"2008-05"},{"nctId":"NCT00843271","phase":"","title":"Endothelial Dysfunction, Biomarkers, and Lung Function -Ancillary to MESA","status":"UNKNOWN","sponsor":"Columbia University","startDate":"2004-10","conditions":["Chronic Obstructive Pulmonary Disease (COPD)","Emphysema","Endothelial Dysfunction"],"enrollment":4359,"completionDate":"2012-11"},{"nctId":"NCT00353795","phase":"NA","title":"Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2005-07","conditions":["Coronary Arteriosclerosis","Arteriosclerosis, Coronary","Atherosclerosis, Coronary","Coronary Artery Disease","Coronary Atherosclerosis"],"enrollment":179,"completionDate":"2008-06"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"_patentsChecked":true,"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Air Force Military Medical University, China","relationship":"Original Developer"},{"period":"present","companyName":"Meda Pharms","relationship":"Current Owner"}],"publicationCount":3192,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"originalDeveloper":"Air Force Military Medical University, China","recentPublications":[{"date":"2026 Mar 1","pmid":"41902502","title":"Estimating population structure using epigenome-wide methylation data.","journal":"Briefings in bioinformatics"},{"date":"2026 Mar 27","pmid":"41891521","title":"Urethral injury during vaginal delivery: Incidence, management and long-term outcomes.","journal":"International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics"},{"date":"2026 Mar 18","pmid":"41891027","title":"CARDIAC-FM: A Multimodal Foundation Model for Cardiovascular Risk Prediction Using ECG and Cardiac MRI.","journal":"medRxiv : the preprint server for health sciences"},{"date":"2026 Mar 26","pmid":"41884897","title":"Plasma Proteins Associated With Psychosocial Factors and Heart Disease: The Jackson Heart Study.","journal":"Arteriosclerosis, thrombosis, and vascular biology"},{"date":"2026 Mar 5","pmid":"41867182","title":"A Common Missense Variant, W335S, in β2-Glycoprotein I (APOH) is Associated with Increased Autoantibody Levels but Reduced Venous Thromboembolism Risk.","journal":"medRxiv : the preprint server for health sciences"}],"companionDiagnostics":[],"genericManufacturers":24,"_genericFilersChecked":true,"genericManufacturerList":["Actavis Labs Fl","Actavis Mid Atlantic","Alembic","Alkem Labs Ltd","Amneal","Amring Pharms","Amta","Annora Pharma","Aurobindo Pharma Ltd","Difgen Pharms","Encube","G And W Labs Inc","Mylan","Novast Labs","Novitium Pharma","Padagis Israel","Quagen","Rising","Sandoz","Sinotherapeutics Inc","Sun Pharm","Teva Pharms Inc","Teva Pharms Usa","Zydus Pharms"],"status":"active","brandName":"MESA","companyName":"Meda Pharms","companyId":"meda-pharms","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:53:07.047005+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}